In vivo biodistribution, biocompatibility, and efficacy of sorafenib-loaded lipid-based nanosuspensions evaluated experimentally in cancer

Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide. In this study, sorafenib-loaded lipid-based nanosuspensions (sorafenib-LNS) were first developed as an intravenous injectable formulation to increase the efficacy of sorafenib against HCC. LNS were used as nanocarri...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Shaomei, Zhang, Bo, Gong, Xiaowei, Wang, Tianqi, Liu, Yongjun, Zhang, Na
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4887074/
https://www.ncbi.nlm.nih.gov/pubmed/27307733
http://dx.doi.org/10.2147/IJN.S104119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4887074/
https://www.ncbi.nlm.nih.gov/pubmed/27307733
http://dx.doi.org/10.2147/IJN.S104119

Ejemplares similares